Skip to main content

Advertisement

SpringerLink
Log in

Preventive treatment of nephrolithiasis with alkali citrate—a critical review

  • Invited Review
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Using the keywords “urolithiasis and citrate treatment”, “nephrolithaisis and citrate treatment”, “kidney stones and citrate treatment”, a Medline search revealed 635 articles published between 1 January 1966 and 1 December 2004. For the present analysis, only studies meeting all of the following criteria were included: (1) publications in English or German, (2) studies on preventive alkali citrate treatment in patients with calcium oxalate, uric acid and infection stone disease, (3) clinical studies including at least ten subjects, and (4) treatment phases of at least 1 week duration. A total of 43 studies met the inclusion criteria and were further subclassified according to intermediate or ultimate endpoints as well as to study design. With stone recurrence as the ultimate endpoint, 21 uncontrolled studies in almost 1,000 patients demonstrated a reduction in stone forming rate by 47–100%. In four randomized controlled trials including 227 patients, 53.5% on alkali citrate vs 35% on placebo remained stone-free after at least 1 year of treatment (P<0.0005). Similar values (66% vs 27.5% for alkali citrate vs placebo, P<0.0005) were obtained in 104 patients from two randomized trials with dissolution/clearance of residual stones as endpoint. Unfortunately, up to 48% of alkali citrate treated patients left the studies prematurely, primarily due to adverse effects such as eructation, bloating, gaseousness or frank diarrhea.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pak CY (1991) Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 17: 420

    CAS  PubMed  Google Scholar 

  2. Erwin DT, Kok DJ, Alam J, Vaughn J, Coker O, Carriere BT et al. (1994) Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macxromolecules larger than 30 kilodalton. Am J Kidney Dis 24: 893

    CAS  PubMed  Google Scholar 

  3. Hess B, Jordi S, Zipperle L, Ettinger E, Giovanoli R (2000) Citrate determines calcium oxalate crystallization kinetics and crystal morphology—studies in presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former. Nephrol Dial Transplant 15: 366

    CAS  PubMed  Google Scholar 

  4. Hamm LL, Hering-Smith KS (2002) Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31: 885

    CAS  PubMed  Google Scholar 

  5. Hess B, Michel R, Takkinen R, Ackermann D, Jaeger P (1994) Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transplant 9: 642

    CAS  PubMed  Google Scholar 

  6. Simpson DP (1983) Citrate excretion: a window on renal metabolism. Am J Physiol 244: F223

    CAS  PubMed  Google Scholar 

  7. Churchill DN (1987) Medical treatment to prevent recurrent calcium urolithiasis. Mineral Eletrolyte Metab 13: 294

    CAS  Google Scholar 

  8. Wang Y-H, Grenabo L, Hedelin H, Pettersson S (1994) The effects of sodium citrate and oral potassium citrate on urease-induced crystallization. Br J Urol 74: 409

    CAS  PubMed  Google Scholar 

  9. Kollwitz AA (1966) Die Behandlung und Prophylaxe von Harnsäuresteinen der Niere durch orale Alkalisierung. Dtsch Med Wochenschr 28: 1257

    Google Scholar 

  10. Uhlir K (1970) The peroral dissolution of renal calculi. J Urol 104: 239

    CAS  PubMed  Google Scholar 

  11. Petritsch PH (1977) Uric acid calculi: results of conservative treatment. Urology 10: 536

    CAS  PubMed  Google Scholar 

  12. Bach D, Hesse A, Strenge A, Vahlensieck W (1980) Harnstein-Prophylaxe mit einer Benzbromaron-Zitrat-Kombination. Fortschr Med 44: 1752

    Google Scholar 

  13. Butz M (1982) Oxalatsteinprophylaxe durch Alkali-Therapie. Urologe A 21: 142

    CAS  PubMed  Google Scholar 

  14. Pak CY, Sakhaee K, Fuller CJ (1983) Physiological and physicochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians 96: 294

    CAS  PubMed  Google Scholar 

  15. Nicar MJ, Peterson R, Pak CY (1984) Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 131: 430

    CAS  PubMed  Google Scholar 

  16. Pak CY, Peterson R, Sakhaee K, Fuller C, Preminger G, Reisch J (1985) Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 79: 284

    CAS  PubMed  Google Scholar 

  17. Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F (1985) Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134: 11

    CAS  PubMed  Google Scholar 

  18. Preminger GM, Peterson R, Peters PC, Pak CY (1985) The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal. J Urol 134: 6

    CAS  PubMed  Google Scholar 

  19. Pak CY, Fuller C (1986) Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Int Med 104: 33

    CAS  PubMed  Google Scholar 

  20. Pak CY, Peterson R (1986) Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med 146: 863

    CAS  PubMed  Google Scholar 

  21. Pak CY, Sakhaee K, Fuller C (1986) Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 30: 422

    CAS  PubMed  Google Scholar 

  22. Nicar MJ, Hsu MC, Fetner C (1986) Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Clin Ther 8: 219

    CAS  PubMed  Google Scholar 

  23. Higashihara E, Nutahara K, Niijima T (1988) Renal hypercalciuria and metabolic acidosis associated with medullary sponge kidney: effect of alkali therapy. Urol Res 16: 95

    CAS  PubMed  Google Scholar 

  24. Hauser W, Frick J, Kunit G (1990). Alkali citrate for preventing recurrence of calcium oxalate stones. Eur Urol 17: 248

    CAS  PubMed  Google Scholar 

  25. Lindberg J, Harvey J, Pak CY (1990) Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol 143: 248

    CAS  PubMed  Google Scholar 

  26. Rodman JS (1991) Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts. J Urol 145: 97

    CAS  PubMed  Google Scholar 

  27. Herrmann U, Schwille PO, Schwarzlaender H, Berger I, Hoffmann G (1992) Citrate and recurrent idiopathic calcium urolithiasis: a longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients (version I). Urol Res 20: 347

    CAS  PubMed  Google Scholar 

  28. Schwille PO, Herrmann U, Wolf C, Berger I, Meister R (1992) Citrate and recurrent idiopathic calcium urolithiasis: a longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients (version II). Urol Res 20: 145

    CAS  PubMed  Google Scholar 

  29. Pak CY, Koenig K, Khan R, Haynes S, Padalino P (1992) Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 7: 281

    CAS  PubMed  Google Scholar 

  30. Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T (1992) Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers. Clin Nephrol 37: 14

    CAS  PubMed  Google Scholar 

  31. Berg C, Larsson L, Tiselius HG (1992) The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation. J Urol 148: 979

    CAS  PubMed  Google Scholar 

  32. Khanniazi MK, Khanam A, Naqvi SA, Sheikh MA (1993) Study of potassium citrate treatment of crystalluric nephrolithiasis. Biomed Pharmacother 47: 25

    CAS  PubMed  Google Scholar 

  33. Wabner CL, Pak CY (1993) Effect of orange juice consumption on urinary stone risk factors. J Urol 149: 1405

    CAS  PubMed  Google Scholar 

  34. Abdulhadi MH, Hall PM, Streem SB (1993) Can citrate therapy prevent nephrolithiasis? Urology 41: 221

    CAS  PubMed  Google Scholar 

  35. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urology 150: 1761

    CAS  Google Scholar 

  36. Kocvara R, Louzensky G, Tuikova J (1994) Development of metaphylaxis in calcium urolithiasis: a restriction of conventional drug therapy. Int Urol Nephrol 26: 269

    CAS  PubMed  Google Scholar 

  37. Hofbauer J, Hobarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis—a prospective randomized study. Br J Urol 73: 362

    CAS  PubMed  Google Scholar 

  38. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B et al. (1994) Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151: 5

    CAS  PubMed  Google Scholar 

  39. Fine JK, Pak CY, Preminger GM (1995) Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153: 27

    CAS  PubMed  Google Scholar 

  40. Whalley NA, Meyers AM, Martins M, Margolius LP (1996) Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78: 10

    CAS  PubMed  Google Scholar 

  41. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069

    CAS  PubMed  Google Scholar 

  42. Grases F, Conte A, March JG, Garcia-Ferragut L (1998) Evolution of lithogenic urinary parameters with a low dose potassium citrate treatment. Int Urol Nephrol 30: 1

    CAS  PubMed  Google Scholar 

  43. Fuselier HA, Moore K, Lindberg J, Husserl FE, Cole FE, Kok DJ et al. (1998) Agglomeration inhibition reflected stone forming activity during long-term potassium citrate therapy in calcium stone formers. Urology 52: 988

    CAS  PubMed  Google Scholar 

  44. Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161: 1453

    CAS  PubMed  Google Scholar 

  45. Ruml LA, Pak CY (1999) Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am J Kidney Dis 34: 107

    CAS  PubMed  Google Scholar 

  46. Premgamone A, Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsupan N, Apinives C (2001) A long-term study on the efficacy of a herbal plant, orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health 32: 654

    CAS  PubMed  Google Scholar 

  47. Soygür T, Akbay A, Kupeli S (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16: 149

    PubMed  Google Scholar 

  48. Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD (2003) Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 169: 465

    CAS  PubMed  Google Scholar 

  49. Siener R, Glatz S, Nicolay C, Hesse A (2003) Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol 44: 467

    PubMed  Google Scholar 

  50. Mardis HK, Parks JH, Muller G, Ganzel K, Coe FL (2004) Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. J Urol 171: 85

    PubMed  Google Scholar 

  51. Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Toshukhowong P, Tungsanga K et al. (2004) The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. J Med Assoc Thai 87: 255

    PubMed  Google Scholar 

  52. Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13: 679

    CAS  PubMed  Google Scholar 

  53. Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs 2000. Eur Urol 44: 709

    CAS  PubMed  Google Scholar 

  54. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63: 1817

    PubMed  Google Scholar 

  55. Shekarriz B, Stoller ML (2002) Cystinuria and other noncalcareous calculi. Endocrinol Metab Clin N Am 31: 951

    CAS  Google Scholar 

  56. Kessler T, Hesse A (2000) Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy subjects. Br J Nutr 84: 865

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. B. Hess

    Present address: Internal Medicine/Nephrology, Klinik Im Park, 8027 Zurich, Switzerland

Authors and Affiliations

  1. Department of Internal Medicine, Regional Hospital, 3600 Thun, Switzerland

    D. Mattle

  2. Department of Internal Medicine/Nephrology, Hospital Zimmerberg, 8820 Wädenswil/Zurich, Switzerland

    B. Hess

Authors
  1. D. Mattle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Hess.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattle, D., Hess, B. Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33, 73–79 (2005). https://doi.org/10.1007/s00240-005-0464-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-005-0464-8

Keywords

Search

Navigation